ABBV
AbbVie Inc.
- Research and development, 2025
- $9.1B
- YoY, 2025
- −28.9%
- 5-year CAGR
- +7.4%
- 10-year CAGR
- +7.8%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| 2025 | $9.1B | −28.9% |
| 2024 | $12.8B | +66.7% |
| 2023 | $7.7B | +17.9% |
| 2022 | $6.5B | −6.0% |
| 2021 | $6.9B | +8.5% |
| 2020 | $6.4B | −0.4% |
| 2019 | $6.4B | −38.0% |
| 2018 | $10.3B | +106.3% |
| 2017 | $5.0B | +14.2% |
| 2016 | $4.4B | +2.3% |
| 2015 | $4.3B | +30.0% |
| 2014 | $3.3B | +15.5% |
| 2013 | $2.9B | +2.8% |
| 2012 | $2.8B | +6.1% |
| 2011 | $2.6B | — |